Clinical Study
Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia
Table 3
Nonhematological adverse events.
| Toxicity | Number of patients (%) |
| Liver toxicity (Grade 2) | 1 (4) |
| Mucositis | | (i) Grade 1 (mild) | 1 (4) | (ii) Grade ≥ 2 (moderate-severe) | 2 (8) |
| Cerebellar toxicity | 2 (8) |
| Neutropenic fever | 10 (38) |
| Infection | | (i) Fungal pneumonia | 4 (15) | (ii) Pneumonia, unknown pathogen | 1 (4) | (iii) Bacteremia | 4 (15) | (iv) Cellulitis | 1 (4) |
| Skin toxicity | 2 (8) |
| Other toxicities: nausea (1) and pericardial effusion (n = 1) |
|
|